| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/01/2011 | US20110212930 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 09/01/2011 | US20110212919 Protein cross-linking inhibitor |
| 09/01/2011 | US20110212915 Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| 09/01/2011 | US20110212914 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 09/01/2011 | US20110212913 Therapeutic compositions comprising phenolic acids for treating conditions related to inappropriate platelet aggregation |
| 09/01/2011 | US20110212907 Hexadecasaccharides with antithrombotic activity, including a covalent bond and an amino chain |
| 09/01/2011 | US20110212529 Muscle-specific expression vectors |
| 09/01/2011 | US20110212178 Injectable Hydrogel Filaments For Biomedical Uses |
| 09/01/2011 | US20110212150 Process for the treatment of cellulosic molded bones |
| 09/01/2011 | US20110212139 High-density lipoprotein coated medical devices |
| 09/01/2011 | US20110212096 Anti-p-selectin antibodies and methods of their use and identification |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212054 Thrombopoietin mimetics |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110212047 Polymer Therapy for the Treatment of Chronic Microvascular Diseases |
| 09/01/2011 | CA2791171A1 Apixaban formulations |
| 09/01/2011 | CA2791103A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2,3-d] pyrimidines having mnk1/ mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | CA2789750A1 Ghrelin receptor agonist for treatment of cachexia |
| 08/31/2011 | EP2362218A2 Methods of monitoring the efficacy of farnesyltransferase inhibitors |
| 08/31/2011 | EP2361918A1 Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein |
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |
| 08/31/2011 | EP2361907A1 The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof |
| 08/31/2011 | EP2214659B1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 08/31/2011 | CN1863798B 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 08/31/2011 | CN1659162B Tricyclic thrombin receptor antagonists |
| 08/31/2011 | CN102171329A Lactic acid bacterium having high oxalic acid decomposition ability |
| 08/31/2011 | CN102170919A Tissue plug |
| 08/31/2011 | CN102170885A Pharmaceutical composition for oral administration |
| 08/31/2011 | CN102168062A Human pulmonary artery smooth muscle cell separation and culturing method and application of same |
| 08/31/2011 | CN102167752A Preparation method of water-soluble soybean polysaccharide ferrous coordination compound |
| 08/31/2011 | CN102167695A Benzimidazole-carbonyl-pyridine-amino-ehtyl-propionate hemihyrate and its use |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166347A New medicinal application of interleukin-12 |
| 08/31/2011 | CN102166345A Medicinal composition containing small amount of desmopressin |
| 08/31/2011 | CN102166340A Chinese medicine composition for treating sthenia heat edema |
| 08/31/2011 | CN102166329A Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof |
| 08/31/2011 | CN102166287A Recovery mud moxibustion and preparation method |
| 08/31/2011 | CN102166245A Oil in water type blumea oil nanoemulsion and preparation method thereof |
| 08/31/2011 | CN102166241A Panax notoginseng saponins enteric microcapsule |
| 08/31/2011 | CN102166226A Production process of posterior pituitary solution |
| 08/31/2011 | CN102166216A Lactulose oral solution and quality control method thereof |
| 08/31/2011 | CN102166214A Medical application of aminothiazole type MyD88 specific inhibitor |
| 08/31/2011 | CN101879232B Medicament for dissipating stasis, removing stroke and preventing and treating cardiovascular and cerebrovascular diseases |
| 08/31/2011 | CN101856431B Medicament for treating liver-kidney yin deficiency type anovulatory dysfunctional uterine bleeding, and preparation method and application thereof |
| 08/31/2011 | CN101773660B Medicament containing anubi-polypeotide |
| 08/31/2011 | CN101708184B Medicine application of iron liposome |
| 08/31/2011 | CN101659640B Ozagrel tromethamine, compound, preparation method and application thereof |
| 08/31/2011 | CN101628054B Medicine for treating ischemic stroke and sequela thereof |
| 08/31/2011 | CN101549066B Prescription for treating allergy purpura and method for preparing same |
| 08/31/2011 | CN101467983B Menatetrenone soft capsule and preparation method thereof |
| 08/31/2011 | CN101380294B Preparation method of solid dispersion medicine for treating hemorrhage |
| 08/31/2011 | CN101306118B Prepared traditional Chinese medicine pill for treating leukemia |
| 08/31/2011 | CN101223167B Novel heteroaryl fused cyclic amines |
| 08/30/2011 | US8008440 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | CA2440473C Metalloproteinase inhibitors |
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/30/2011 | CA2393352C Adamantane derivatives |
| 08/25/2011 | WO2011103382A2 Compositions and methods for inducing angiogenesis |
| 08/25/2011 | WO2011102505A1 Sustained-release solid preparation for oral use |
| 08/25/2011 | WO2011102504A1 Sustained-release solid preparation for oral use |
| 08/25/2011 | WO2011101740A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
| 08/25/2011 | WO2011075004A9 Anti-thrombosis aptamers and method for stabilizing the structure thereof |
| 08/25/2011 | WO2011060066A9 Methods of treating or preventing stent thrombosis |
| 08/25/2011 | US20110209248 Novel sugar transporters |
| 08/25/2011 | US20110208159 Catheter Locking Composition |
| 08/25/2011 | US20110207797 Enhanced antisense oligonucleotides |
| 08/25/2011 | US20110207764 Cyclopolysaccharide compositions |
| 08/25/2011 | US20110207742 Method for reduction, stabilization and prevention of rupture of lipid rich plaque |
| 08/25/2011 | US20110207724 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anit-hypertensive compounds |
| 08/25/2011 | US20110207710 Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapies |
| 08/25/2011 | US20110207669 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation |
| 08/25/2011 | US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof |
| 08/25/2011 | US20110207224 In vivo production of small interfering rnas that mediate gene silencing |
| 08/25/2011 | US20110206794 Fruit extracts |
| 08/25/2011 | US20110206784 Composition for the prevention and treatment of postmenopausal syndrome containing extracts or fractions of aceriphyllum rossii as an effective ingredient |
| 08/25/2011 | US20110206781 Method to modulate hematopoietic stem cell growth |
| 08/25/2011 | US20110206771 Encapsulated functional fine particle composition capable of spraying and preparation method thereof |
| 08/25/2011 | US20110206760 Angiopoietin derived peptides |
| 08/25/2011 | US20110206667 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment |
| 08/25/2011 | US20110206656 Emergency interventions of active charcoal with dabigatran etexilate overdosing |
| 08/25/2011 | US20110206655 Fviii-independent fix-mutant proteins for hemophilia a treatment |
| 08/25/2011 | US20110206653 Tetrazole compounds for reducing uric acid |
| 08/25/2011 | US20110206652 Methods for treating atherosclerosis |
| 08/25/2011 | US20110206651 Factor viii polymer conjugates |
| 08/25/2011 | US20110206644 Methods for trans-differentiating cells |
| 08/25/2011 | US20110206631 Ion binding polymers and uses thereof |
| 08/25/2011 | CA2788072A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
| 08/24/2011 | EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 08/24/2011 | EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/24/2011 | EP2360159A1 Prasugrel in micronized, crystalline form and pharmaceutical compound of same |
| 08/24/2011 | EP2359869A2 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same and uses therefor |
| 08/24/2011 | EP2359868A1 Vector encoding human globulin gene and use thereof in treatment of hemoglobinopathies |
| 08/24/2011 | EP2359855A2 Methods of administering anti-TNFalpha antibodies |
| 08/24/2011 | EP2359834A1 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |
| 08/24/2011 | EP2358706A1 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 08/24/2011 | EP2358368A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |